Short description
HAVAH Therapeutics is focused on developing better hormonal therapies to help millions of women lead longer, better lives.
Description
Originally founded in Australia in 2006, Palo Alto-based HAVAH Therapeutics Inc. is a clinical-stage pharmaceutical company specialising in the development of novel therapeutics for the prevention of breast cancer.
Breast cancer prevention is a critical, unmet global need. HAVAH's lead product candidate, T+Ai, is a proprietary breakthrough breast cancer prevention combination therapy - reducing a woman’s risk of breast cancer whilst improving their sense of wellbeing.
Total funding
$$43214321
Sign in for full access
Location
Palo Alto, California, United States, North America
Founded on
January 1, 2006
Non-profit?
No
Acquired?
No
Employees count
1-10
Founders
Nicholas Birrell, Stephen Birrell